Pasteur Approach to a Malaria Vaccine May Take the Lead

Abstract

Malaria is an infectious disease that is responsible for more loss of young lives than any other health condition. Eighty percent of the cases and nearly 1 million deaths from malaria occur in Africa each year. Although mortality has decreased in recent years, more must be done to improve and save the lives of sufferers. On page 1359 of this issue, Seder et al. (1) report that an attenuated form of the causative parasite can be administered intravenously and provide protection against malaria, taking us a step closer to achieving the goal of an effective vaccine.